A citation-based method for searching scientific literature

Roy W Beck, Crystal G Connor, Deborah M Mullen, David M Wesley, Richard M Bergenstal. Diabetes Care 2017
Times Cited: 154



Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
Times Cited: 215




List of shared articles



Times cited

Is HbA1c an ideal biomarker of well-controlled diabetes?
Georgia Kaiafa, Stavroula Veneti, George Polychronopoulos, Dimitrios Pilalas, Stylianos Daios, Ilias Kanellos, Triantafyllos Didangelos, Stamatina Pagoni, Christos Savopoulos. Postgrad Med J 2021
2



Intermittently Scanned Glucose Values for Continuous Monitoring: Cross-Sectional Analysis of Glycemic Control and Hypoglycemia in 1809 Children and Adolescents with Type 1 Diabetes.
Torben Biester, Julia M Grimsmann, Bettina Heidtmann, Birgit Rami-Merhar, Uwe Ermer, Johannes Wolf, Markus Freff, Beate Karges, Dirk Agena, Peter Bramlage,[...]. Diabetes Technol Ther 2021
2

Improved Estimation of Glycated Hemoglobin from Continuous Glucose Monitoring and Past Glycated Hemoglobin Data.
Jędrzej Chrzanowski, Arkadiusz Michalak, Aleksandra Łosiewicz, Hanna Kuśmierczyk, Beata Mianowska, Agnieszka Szadkowska, Wojciech Fendler. Diabetes Technol Ther 2021
2

Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C).
Thomas W Martens, Richard M Bergenstal, Teresa Pearson, Anders L Carlson, Gary Scheiner, Campos Carlos, Birong Liao, Kristen Syring, Roy Daniel Pollom. Postgrad Med 2021
0

Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections.
Sara Hallström, Irl B Hirsch, Magnus Ekelund, Sheyda Sofizadeh, Henrik Albrektsson, Solveig Dahlqvist, Ann-Marie Svensson, Marcus Lind. Diabetes Technol Ther 2021
1

THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
Simon Helleputte, Tine De Backer, Patrick Calders, Bart Pauwels, Samyah Shadid, Bruno Lapauw. Endocr Pract 2021
1

Association between time in range, a novel measurement of glycemic control and islet secretory function in chinese patients with type 2 diabetes mellitus-An observational study.
Shao-Ying Xu, KeLi, Zhen Zhang, Chun-Yan Liu, Qing-Yu Guo, Bin Lu, Ping Gu, Jia-Qing Shao. Diabetes Res Clin Pract 2021
0

The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring.
Gonzalo Díaz-Soto, M Pilar Bahíllo-Curieses, Rebeca Jimenez, Maria de la O Nieto, Emilia Gomez, Beatriz Torres, Juan Jose López Gomez, Daniel de Luis. Endocrinol Diabetes Nutr 2021
2

Glycemic deviation index: a novel method of integrating glycemic numerical value and variability.
Yizhou Zou, Wanli Wang, Dongmei Zheng, Xu Hou. BMC Endocr Disord 2021
0

Glucodensities: A new representation of glucose profiles using distributional data analysis.
Marcos Matabuena, Alexander Petersen, Juan C Vidal, Francisco Gude. Stat Methods Med Res 2021
0


American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.
George Grunberger, Jennifer Sherr, Myriam Allende, Thomas Blevins, Bruce Bode, Yehuda Handelsman, Richard Hellman, Rosemarie Lajara, Victor Lawrence Roberts, David Rodbard,[...]. Endocr Pract 2021
7

Time-in-range for monitoring glucose control: Is it time for a change?
Virginia Bellido, Pedro José Pinés-Corrales, Rocío Villar-Taibo, Francisco Javier Ampudia-Blasco. Diabetes Res Clin Pract 2021
0



Time in Range as a Research Outcome Measure.
Joseph G Timmons, James G Boyle, John R Petrie. Diabetes Spectr 2021
0

Associations of Time in Range and Other Continuous Glucose Monitoring-Derived Metrics With Well-Being and Patient-Reported Outcomes: Overview and Trends.
Dominic Ehrmann, Lilli Priesterroth, Andreas Schmitt, Bernhard Kulzer, Norbert Hermanns. Diabetes Spectr 2021
1

Relationship between time in range, glycemic variability, HbA1c and complications in adults with type 1 diabetes mellitus.
Anass El Malahi, Michiel Van Elsen, Sara Charleer, Eveline Dirinck, Kristien Ledeganck, Bart Keymeulen, Laurent Crenier, Régis Radermecker, Youri Taes, Chris Vercammen,[...]. J Clin Endocrinol Metab 2021
0

Assessment of Hyperglycemia, Hypoglycemia and Inter-Day Glucose Variability Using Continuous Glucose Monitoring among Diabetic Patients on Chronic Hemodialysis.
Maria Divani, Panagiotis I Georgianos, Triantafyllos Didangelos, Vassilios Liakopoulos, Kali Makedou, Fotios Iliadis, Christos Savopoulos, Dimitrios M Grekas. J Clin Med 2021
0

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Richard I G Holt, J Hans DeVries, Amy Hess-Fischl, Irl B Hirsch, M Sue Kirkman, Tomasz Klupa, Barbara Ludwig, Kirsten Nørgaard, Jeremy Pettus, Eric Renard,[...]. Diabetologia 2021
0

The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Richard I G Holt, J Hans DeVries, Amy Hess-Fischl, Irl B Hirsch, M Sue Kirkman, Tomasz Klupa, Barbara Ludwig, Kirsten Nørgaard, Jeremy Pettus, Eric Renard,[...]. Diabetes Care 2021
0

Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes.
Zhou-Qin Feng, Qing-Yu Guo, Wei Wang, Yan-Yu Yuan, Xu-Guang Jin, Hui Zhou, Jun Liu, Hai-Yan Lei, Xin-Yi Yang, Jun Liu,[...]. Diabetol Metab Syndr 2021
0

Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
Suresh Rama Chandran, Robert A Vigersky, Andreas Thomas, Lee Ling Lim, Jeyakantha Ratnasingam, Alexander Tan, Daphne S L Gardner. Diabetes Technol Ther 2020
5

Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Yun Shen, Qiang Wu, Ren Wang, Lei Zhang, Yifei Mo, Wei Lu, Wei Zhu, Yuqian Bao,[...]. Diabetes Technol Ther 2020
53

HbA1c: The Glucose Management Indicator, Time in Range, and Standardization of Continuous Glucose Monitoring Reports in Clinical Practice.
Anders L Carlson, Amy B Criego, Thomas W Martens, Richard M Bergenstal. Endocrinol Metab Clin North Am 2020
12


Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes.
Jee Hee Yoo, Min Sun Choi, Jiyeon Ahn, Sung Woon Park, Yejin Kim, Kyu Yeon Hur, Sang-Man Jin, Gyuri Kim, Jae Hyeon Kim. Diabetes Technol Ther 2020
23

Time in range: a new parameter to evaluate blood glucose control in patients with diabetes.
Monica Andrade Lima Gabbay, Melanie Rodacki, Luis Eduardo Calliari, Andre Gustavo Daher Vianna, Marcio Krakauer, Mauro Scharf Pinto, Janice Sepúlveda Reis, Marcia Puñales, Leonardo Garcia Miranda, Ana Claudia Ramalho,[...]. Diabetol Metab Syndr 2020
16

Monitoring of Pediatric Type 1 Diabetes.
Brynn E Marks, Joseph I Wolfsdorf. Front Endocrinol (Lausanne) 2020
7

Associations between acute glucose control and peripheral nerve structure and function in type 1 diabetes.
T Issar, S S Tummanapalli, N C G Kwai, J C B Chiang, R Arnold, A M Poynten, M Markoulli, A V Krishnan. Diabet Med 2020
3


Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
Rodolfo J Galindo, Roy W Beck, Maria F Scioscia, Guillermo E Umpierrez, Katherine R Tuttle. Endocr Rev 2020
11

Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need?
Chiara Fabris, Lutz Heinemann, Roy Beck, Claudio Cobelli, Boris Kovatchev. Diabetes Technol Ther 2020
15


Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis.
Anthony Pease, Clement Lo, Arul Earnest, Velislava Kiriakova, Danny Liew, Sophia Zoungas. Diabetes Care 2020
10